search
Back to results

Ketogenic Diet Following Moderate to Severe Pediatric Traumatic Brain Injury

Primary Purpose

Traumatic Brain Injury

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Ketogenic Diet
Sponsored by
Gillette Children's Specialty Healthcare
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Traumatic Brain Injury

Eligibility Criteria

2 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age limits met at the time of injury and admission
  • Participants with moderate to severe traumatic brain injury defined as a Glasgow Coma Scale Score of 3-12 (lowest score in the first 24 hours after injury). Individuals requiring craniotomy and/or evacuation of intracranial hemorrhage may be included.

Exclusion Criteria:

  • Currently on an oral diet at time of screening or currently on IV-only and in opinion of Pediatric Intensive Care Unit intensivist will be transitioning to an oral diet, not tube-feeding
  • Anoxia/ischemia as a significant portion of injury, including near-drowning
  • Non-accidental traumatic brain injury (i.e., assault, abuse)
  • Penetrating injury including gunshot wounds
  • Pregnancy
  • Any condition that in the opinion of the Pediatric Intensive Care Unit or neurosurgery medical staff warrants exclusion from the study

Sites / Locations

  • Gillette Children's Specialty HealthcareRecruiting
  • Children's MinnesotaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Prospective Intervention Group

Historical Control Group

Arm Description

Participants will receive standard of care for acute management of moderate to severe traumatic brain injury, together with a weight-based ketogenic diet added for up to fourteen days.

Medical records of past TBI patients will be used as controls matched for age, gender, socioeconomic status (type of health care coverage including private insurance vs. government-funded coverage), lowest first 24 hour post-injury Glasgow Coma Score (GCS) (<8 or 8-12), and pre-injury school program (regular or special education).

Outcomes

Primary Outcome Measures

Ability to complete a course of the ketogenic diet (KD)
Safety and feasibility will be determined by the ability to complete a 14-day course of the KD after TBI without needing to terminate the diet due to intolerance resulting from gastrointestinal side effects (for example, nausea and vomiting, diarrhea, or acidosis), or due to abnormal findings on laboratory tests. Outcome is reported as the number of participants who complete the 14-day keto diet treatment.

Secondary Outcome Measures

Duration of Unconsciousness
Outcome is reported as the length of time (in hours) a participant is unconscious following their injury.
Need for Surgeries
Outcome is reported as the number of surgeries required in each group following injury.
Duration of Acute Hospitalization
Outcome is reported as the length (in days) of acute hospitalization following injury.
Duration of Post-traumatic Amnesia
Outcome is reported as the length of time (in days) that a participant experiences amnesia following their injury.

Full Information

First Posted
June 17, 2021
Last Updated
September 15, 2023
Sponsor
Gillette Children's Specialty Healthcare
Collaborators
State of Minnesota Spinal Cord Injury and Traumatic Brain Injury Research Grant Program, Children's Minnesota
search

1. Study Identification

Unique Protocol Identification Number
NCT04933448
Brief Title
Ketogenic Diet Following Moderate to Severe Pediatric Traumatic Brain Injury
Official Title
Ketogenic Diet Following Moderate to Severe Pediatric Traumatic Brain Injury: A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 16, 2022 (Actual)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
September 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Gillette Children's Specialty Healthcare
Collaborators
State of Minnesota Spinal Cord Injury and Traumatic Brain Injury Research Grant Program, Children's Minnesota

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The primary objective of this study is to evaluate the feasibility and safety of using the ketogenic diet (KD) in children who sustained moderate to severe traumatic brain injury (TBI). The secondary objective is a preliminary evaluation of the outcomes of children who have had the standard of care plus the KD, compared to those with standard of care alone. Outcome measures for the secondary objective will include: need for ventriculoperitoneal shunt, duration of unconsciousness, need for any type of craniotomy, duration of post-traumatic amnesia, acute hospitalization length of stay, and cognitive and motor function at 12 months after injury. If this study demonstrates feasibility and safety, the information related to outcomes will be used to inform the planning of a future, larger, randomized study of the efficacy of the KD in children and adolescents with TBI. Specifically, this information will be used to assist with sample size calculations for this future study.
Detailed Description
The KD is an alternative feeding regimen that has been in use since 1921. It is a high fat, low carbohydrate and moderate protein diet. There are various forms of the KD. The classic KD consists of long-chain triglycerides with a fat-to-combined-protein-and-carbohydrate ratio that can vary. At our institution, it is standard of care to initiate a ketogenic diet at a ratio of 2:1, and to increase the ratio to 3:1 or 4:1 as needed to achieve ketosis. Clinically, the KD has been proven to be an effective therapy in children and adolescents with refractory epilepsy, as well as for those with type II diabetes. In addition, an international consensus was published in 2009 that recommended the use of the KD to treat epilepsy refractory as an alternative to at least two antiepileptic medications. Before initiating the KD for epilepsy management, labs such as urine and blood ketones, blood glucose and a basic metabolic panel including magnesium are commonly recommended. Risks for long-term use of the KD include but are not limited to the following: hypercholesterolemia, mineral deficiencies, acidosis, constipation, weight loss and nephrolithiasis. However, short-term use should significantly limit the occurrence of these potential complications.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Traumatic Brain Injury

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Outcomes Assessor
Allocation
Non-Randomized
Enrollment
21 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Prospective Intervention Group
Arm Type
Experimental
Arm Description
Participants will receive standard of care for acute management of moderate to severe traumatic brain injury, together with a weight-based ketogenic diet added for up to fourteen days.
Arm Title
Historical Control Group
Arm Type
No Intervention
Arm Description
Medical records of past TBI patients will be used as controls matched for age, gender, socioeconomic status (type of health care coverage including private insurance vs. government-funded coverage), lowest first 24 hour post-injury Glasgow Coma Score (GCS) (<8 or 8-12), and pre-injury school program (regular or special education).
Intervention Type
Other
Intervention Name(s)
Ketogenic Diet
Other Intervention Name(s)
Keto
Intervention Description
The ketogenic diet (KD) is an alternative feeding regimen that has been in use since 1921. It is a high-fat, low carbohydrate, and moderate protein diet. There are various forms of the KD. The classic KD consists of long-chain triglycerides with a fat-to-combined-protein-and-carbohydrate ratio that can vary. At the investigating institution, it is standard of care to initiate a ketogenic diet at a ratio of 2:1, and to increase the ratio to 3:1 or 4:1 as needed to achieve ketosis.
Primary Outcome Measure Information:
Title
Ability to complete a course of the ketogenic diet (KD)
Description
Safety and feasibility will be determined by the ability to complete a 14-day course of the KD after TBI without needing to terminate the diet due to intolerance resulting from gastrointestinal side effects (for example, nausea and vomiting, diarrhea, or acidosis), or due to abnormal findings on laboratory tests. Outcome is reported as the number of participants who complete the 14-day keto diet treatment.
Time Frame
14 days
Secondary Outcome Measure Information:
Title
Duration of Unconsciousness
Description
Outcome is reported as the length of time (in hours) a participant is unconscious following their injury.
Time Frame
14 days
Title
Need for Surgeries
Description
Outcome is reported as the number of surgeries required in each group following injury.
Time Frame
14 days
Title
Duration of Acute Hospitalization
Description
Outcome is reported as the length (in days) of acute hospitalization following injury.
Time Frame
14 days
Title
Duration of Post-traumatic Amnesia
Description
Outcome is reported as the length of time (in days) that a participant experiences amnesia following their injury.
Time Frame
14 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age limits met at the time of injury and admission Participants with moderate to severe traumatic brain injury defined as a Glasgow Coma Scale Score of 3-12 (lowest score in the first 24 hours after injury). Individuals requiring craniotomy and/or evacuation of intracranial hemorrhage may be included. Exclusion Criteria: Currently on an oral diet at time of screening or currently on IV-only and in opinion of Pediatric Intensive Care Unit intensivist will be transitioning to an oral diet, not tube-feeding Anoxia/ischemia as a significant portion of injury, including near-drowning Non-accidental traumatic brain injury (i.e., assault, abuse) Penetrating injury including gunshot wounds Pregnancy Any condition that in the opinion of the Pediatric Intensive Care Unit or neurosurgery medical staff warrants exclusion from the study
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Linda Krach, MD
Phone
(651)-229-3873
Email
LKrach@gillettechildrens.com
First Name & Middle Initial & Last Name or Official Title & Degree
Angela Sinner, DO
Phone
(651)-325-2317
Email
ASinner@gillettechildrens.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Linda Krach, MD
Organizational Affiliation
Department of Physical Medicine and Rehabilitation
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Angela Sinner, DO
Organizational Affiliation
Department of Physical Medicine and Rehabilitation
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gillette Children's Specialty Healthcare
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55101
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Linda Krach, MD
Phone
651-229-3873
Email
LKrach@gillettechildrens.com
Facility Name
Children's Minnesota
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55404
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Andrew Kiragu, MD
Email
Andrew.Kiragu@childrensmn.org
First Name & Middle Initial & Last Name & Degree
Andrew Kiragu, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Ketogenic Diet Following Moderate to Severe Pediatric Traumatic Brain Injury

We'll reach out to this number within 24 hrs